Compare ORGO & ZSQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ORGO | ZSQR |
|---|---|---|
| Founded | 1985 | 2022 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 181.4M | 204.6M |
| IPO Year | 2016 | 2020 |
| Metric | ORGO | ZSQR |
|---|---|---|
| Price | $1.40 | $3.91 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 534.3K | 375.9K |
| Earning Date | 11-05-2026 | 08-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1600.00 | 50.27 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $564,169,000.00 | $1,363,045.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $37.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 17.04 | N/A |
| 52 Week Low | $1.34 | $2.11 |
| 52 Week High | $7.08 | $16.62 |
| Indicator | ORGO | ZSQR |
|---|---|---|
| Relative Strength Index (RSI) | 31.90 | 58.36 |
| Support Level | $1.34 | $2.81 |
| Resistance Level | $2.55 | $4.64 |
| Average True Range (ATR) | 0.06 | 0.47 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 17.65 | 79.36 |
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.
Z Squared Inc is a computing infrastructure company operating computing equipment and expanding into AI infrastructure. The Company's idea is to build on three principles: guide with power by acquiring operating sites where power is already flowing; build for AI workloads by converting that capacity into AI-ready colocation where the customer brings the compute and runs what it needs; and scale with discipline by deploying conversion capital site by site, against signed contracts and operational readiness.